David L. Silver
Impact in
- Biochemistry top 0.2%
- Lipid metabolism and biosynthesis
- Aging top 2%
Papers in
-
- Peroxisome Proliferator-Activated Receptors 9
- Surgery 28
- Cholesterol and Lipid Metabolism 16
- Pancreatic function and diabetes 12
- Co-authors
- Alan R. Tall (14 shared papers)Nan Wang (6 shared papers)Jun Nakae (2 shared papers)Domenico Accili (2 shared papers)Tadahiro Kitamura (2 shared papers)Long N. Nguyen (10 shared papers)Markus R. Wenk (17 shared papers)Amaury Cazenave‐Gassiot (10 shared papers)
- Journals
- Journal of Biological Chemistry (16 papers)Journal of Clinical Investigation (10 papers)Proceedings of the National Academy of Sciences (6 papers)Nature (4 papers)Drug Metabolism and Disposition (3 papers)
- Partner nations
- United StatesSingaporeUnited Kingdom
In The Last Decade
David L. Silver
80 papers receiving 6.9k citations
David L. Silver's Hit Papers
Peers
Comparison fields: 5 of 119
- Biochemistry 1.1k
- Aging 113
- Surgery 2.4k
- Molecular Biology 3.5k
- Cancer Research 661
Countries citing papers authored by David L. Silver
This map shows the geographic impact of David L. Silver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Silver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Silver more than expected).
Fields of papers citing papers by David L. Silver
This network shows the impact of papers produced by David L. Silver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Silver. The network helps show where David L. Silver may publish in the future.
Co-authors
The 25 scholars most cited alongside David L. Silver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid Hit paper breakdown → | 2014 | 783 |
| 2 | Specific Binding of ApoA-I, Enhanced Cholesterol Efflux, and Altered Plasma Membrane Morphology in Cells Expressing ABC1 Hit paper breakdown → | 2000 | 513 |
| 3 | 2001 | 494 | |
| 4 | 2001 | 482 | |
| 5 | 2001 | 420 | |
| 6 | 2003 | 226 | |
| 7 | 2003 | 217 | |
| 8 | 2001 | 217 | |
| 9 | 2007 | 201 | |
| 10 | 2017 | 190 | |
| 11 | 2011 | 142 | |
| 12 | 2005 | 140 | |
| 13 | 2016 | 128 | |
| 14 | 2015 | 122 | |
| 15 | 2003 | 119 | |
| 16 | 1999 | 113 | |
| 17 | 2000 | 111 | |
| 18 | 2002 | 105 | |
| 19 | 2008 | 104 | |
| 20 | 2000 | 101 |
About David L. Silver
David L. Silver is a scholar working on Molecular Biology, Surgery, Biochemistry, Oncology and Cell Biology, having authored 83 papers that have together received 7.1k indexed citations. Recurring topics across this work include Lipid metabolism and biosynthesis (18 papers), Cholesterol and Lipid Metabolism (16 papers), Drug Transport and Resistance Mechanisms (16 papers), Pancreatic function and diabetes (12 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Endoplasmic Reticulum Stress and Disease (9 papers), Liver Disease Diagnosis and Treatment (9 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Biochemistry (1.1k citations), Aging (113 citations), Surgery (2.4k citations), Molecular Biology (3.5k citations) and Cancer Research (661 citations). David L. Silver has collaborated with scholars based in United States, Singapore and United Kingdom. Frequent co-authors include Alan R. Tall, Nan Wang, Jun Nakae, Domenico Accili, Tadahiro Kitamura, Long N. Nguyen, Markus R. Wenk, Amaury Cazenave‐Gassiot, Philippe Costet and David A. Gross. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Nature and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.